Safety and Efficacy of Empagliflozin in Hemodialysis (SEED)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    End Stage Renal Disease (esrd)
  • Age: Between 18 Year(s) - 90 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Undergoing in-center, three-times weekly hemodialysis for treatment of end-stage renal disease (ESRD);
    2. Less than 1 year since dialysis initiation.

You may not be eligible for this study if the following are true:

    1. Currently incarcerated;
    2. Life expectancy, kidney transplant, change in dialysis modality, or change to non-participating HD unit anticipated within 6 months;
    3. Allergy to study medication;
    4. Type 1 Diabetes.



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.